Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Alibaba Stock Rises 28% in 6 Months: Hold Tight or Time to Let Go?
Alibaba Stock Rises 28% in 6 Months: Hold Tight or Time to Let Go?

Alibaba BABA shares have surged 28% in the past six-month period, outperforming the Zacks Internet – Commerce industry and the Zacks Retail-Wholesale sector. While the rally has rewarded

Leidos Holdings Q4 Earnings Beat Estimates, Revenues Decline Y/Y
Leidos Holdings Q4 Earnings Beat Estimates, Revenues Decline Y/Y

Leidos Holdings, Inc.’s LDOS fourth-quarter 2025 adjusted earnings of $2.76 per share beat the Zacks Consensus Estimate of $2.57 by 7.4%. The bottom line also improved 16.5% from $2.37 registered in

Amazon vs. Alibaba: Which E-Commerce Titan Has an Edge Right Now?
Amazon vs. Alibaba: Which E-Commerce Titan Has an Edge Right Now?

Amazon AMZN and Alibaba Group BABA are the world's two largest e-commerce and cloud computing empires. Both are aggressively investing in AI and cloud infrastructure, making this comparison timely

BOOT & 3 Other Stocks With Strong Interest Coverage to Buy Now
BOOT & 3 Other Stocks With Strong Interest Coverage to Buy Now

Relying solely on stock price movements without understanding the company’s fundamentals can cause investors to lose money. Investors must carefully review a company's financial health to make

SMCI Declines 6% in a Month: Time to Hold or Fold the Stock?
SMCI Declines 6% in a Month: Time to Hold or Fold the Stock?

Super Micro Computer SMCI shares have lost 6.4% in the past month, underperforming the Zacks Computer- Storage Devices industry’s appreciation of 25% and the Zacks Computer and Technology sector’s

SMR vs. BWXT: Which Small Modular Reactor Stock is a Buy Right Now?
SMR vs. BWXT: Which Small Modular Reactor Stock is a Buy Right Now?

NuScale Power SMR and BWX Technologies BWXT are both important companies in the nuclear energy industry. NuScale Power focuses on building small modular reactors for clean energy projects. BWX

Industrial, Automotive and Consumer Growth to Drive ADI's Q1 Earnings
Industrial, Automotive and Consumer Growth to Drive ADI's Q1 Earnings

Analog Devices ADI is set to report its first-quarter fiscal 2026 results on Feb. 18, and investor attention is firmly focused on ADI’s growth across its segments.

Analog Devices has been

Pre-Markets Begins Shorter Week Slowly: https://staticx-tuner.zacks.com/images/articles/main/6d/146644.webp
Pre-Markets Begins Shorter Week Slowly

Tuesday, February 17th, 2026Pre-market indexes begin our holiday-shortened trading week bouncing around in the red at this hour. Following a Presidents Day respite, we look to be slowly rolling off

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?

Shares of CorMedix CRMD have witnessed a sharp decline over the past three months. A key reason for the stocks’ decline during this time has been the company’s bearish 2026 financial outlook. In

Garrett Gears Up to Report Q4 Earnings: What's in the Cards?
Garrett Gears Up to Report Q4 Earnings: What's in the Cards?

Garrett Motion Inc. GTX is slated to release fourth-quarter 2025 results on Feb. 19, before market open. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share (EPS) and

Micron’s Run Isn’t Over—3 Signals Point to More Upside
Micron’s Run Isn’t Over—3 Signals Point to More Upside

Micron’s (NASDAQ: MU) stock price has struggled in early 2026, hitting a fresh high before stalling. There is a risk this rally is over, but indicators, including chart technicals, analyst

Vulcan Stock Down as Q4 Earnings & Revenues Miss Estimates
Vulcan Stock Down as Q4 Earnings & Revenues Miss Estimates

Vulcan Materials Company VMC reported lower-than-expected fourth-quarter 2025 results, with adjusted earnings and revenues missing the Zacks Consensus Estimate. On a year-over-year basis, the top

Carvana Gears Up to Report Q4 Earnings: What's in the Cards?
Carvana Gears Up to Report Q4 Earnings: What's in the Cards?

Carvana Co. CVNA is slated to release fourth-quarter 2025 results on Feb. 18, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share (EPS) and

Top Wind Energy Stocks Worth Investing Now For Solid Returns
Top Wind Energy Stocks Worth Investing Now For Solid Returns

An updated edition of the Dec. 26, 2025 article.Renewable energy is increasingly recognized for its significant role in combating climate change, transforming from an alternative source to a

Cenovus Energy's Q4 Earnings on Deck: Should You Exit or Stay Invested?
Cenovus Energy's Q4 Earnings on Deck: Should You Exit or Stay Invested?

Cenovus Energy Inc. CVE is set to report fourth-quarter 2025 results on Feb. 19, 2026, before the opening bell.

The Zacks Consensus Estimate for fourth-quarter earnings is pegged at 28 cents per

Is Sprouts Farmers Set for Another Surprise This Earnings Season?
Is Sprouts Farmers Set for Another Surprise This Earnings Season?

With Sprouts Farmers Market, Inc. SFM set to announce its fourth-quarter 2025 earnings results on Feb. 19, after the market closes, investors are faced with a critical question: Can SFM continue its

How to Approach Penske Automotive Stock Post Q4 Earnings?
How to Approach Penske Automotive Stock Post Q4 Earnings?

Penske Automotive Group PAG entered 2026 with a solid financial foundation and diversified operations, including high-margin service, parts, and luxury dealership segments. While acquisitions and

Airship AI Holdings, Inc. (AISP) Reports Q4 Loss, Misses Revenue Estimates
Airship AI Holdings, Inc. (AISP) Reports Q4 Loss, Misses Revenue Estimates

Airship AI Holdings, Inc. (AISP) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago. These figures are

Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market
Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market

Labcorp Holdings LH or Labcorp reported fourth-quarter 2025 adjusted earnings per share (EPS) of $4.07, which beat the Zacks Consensus Estimate by 3%. The figure rose 18% from the year-ago level.

DTE Energy's Q4 Earnings Beat Estimates, Increase Year Over Year
DTE Energy's Q4 Earnings Beat Estimates, Increase Year Over Year

DTE Energy Company DTE reported fourth-quarter 2025 operating earnings per share (EPS) of $1.65, which beat the Zacks Consensus Estimate of $1.52 by 8.6%. The bottom line increased 9.3% from the

Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?

Arcutis Biotherapeutics ARQT is scheduled to report fourth-quarter and full-year 2025 results on Feb. 25, after market close. We expect investors to focus on the sales performance of ARQT’s marketed

MongoDB Benefits From a Strong Partner Network: Can it Drive Growth?
MongoDB Benefits From a Strong Partner Network: Can it Drive Growth?

MongoDB's MDB expanding partner network is emerging as a structural growth lever, embedding the platform deeper into the modern enterprise software stack. Integrations with LangChain for AI

Can Rising Defense Demand Boost Celestica's Future Growth Prospects?
Can Rising Defense Demand Boost Celestica's Future Growth Prospects?

Celestica Inc. CLS plays a key role in the global defense industry by designing, engineering and manufacturing high-reliability electronic systems for mission-critical military applications. It acts

Will the Iron Drone Raider Win Ignite Ondas' Long-Term Growth Engine?
Will the Iron Drone Raider Win Ignite Ondas' Long-Term Growth Engine?

Ondas Inc. ONDS has taken a major initiative to commercialize its autonomous defense technologies. Through its subsidiary Airobotics, the company has secured a new multi-million-dollar order from a

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

Novocure NVCR recently announced the FDA approval for its portable therapeutic device, Optune Pax, for treating adult patients with locally advanced pancreatic cancer concomitant with gemcitabine